DEVELOPMENT AND MANUFACTURE OF MICROBIAL-DERIVED BIOPHARMACEUTICALS
Richter-Helm is a leading and steadily growing biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with two cGMP-compliant manufacturing facilities in Germany.
We specialize in products derived from bacteria and yeasts. Over the past 30 years we gained substantial experience in the development and manufacture of different product types that include recombinant proteins and peptides, plasmid DNA, and bacterial vaccines.
We move our clients projects forward: flexible, transparent, fast
Our Microbial Capabilities
Our company in numbers
How Richter-Helm Overcomes the Challenges of the Covid-19 Pandemic
Richter-Helm´s Biomanufacturing Facility Expansion progress: inauguration of the new office building
Richter-Helm BioLogics has reached a further and important construction milestone during the expansion of its production site in Bovenau. We officially and ceremoniously inaugurated the new office building on May 31, 2023 together with the mayor of Bovenau, Mr. Ambrock, two years after the groundbreaking ceremony.
Nykode Therapeutics and Richter-Helm BioLogics Announce Strategic Manufacturing Partnership
Oslo, Norway, December 19, 2022 – Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced that it has entered into a strategic manufacturing partnership with Richter-Helm BioLogics GmbH & Co KG to supply plasmid DNA for Nykode’s wholly owned and partnered product portfolio.
Biotech-Unternehmen mit ausgezeichneter Recruiting-DNA
We at Richter-Helm are extremely proud of being awarded the Recruiting-Excellence-Audit® (RExA) of jobware.de. Our whole recruiting processes were analyzed based on hundreds of factors. User-friendliness of the online application form, the job interviews and the onboarding at Richter-Helm all showed great performance. “Richter-Helm responds quickly and professionally to applicants requests. The subsequent onboarding is also exemplary. 83 percent of the new colleagues rated this as good or very good.” stated Jobware.de.
Translating Three Decades of Experience in Plasmid DNA Into Customer Success
Richter-Helm’s Managing Director Kai Pohlmeyer, Ph.D., and Director of Business Development Thilo Kamphausen, Ph.D., discuss the company’s upcoming expansion in Bovenau, Germany, how pDNA manufacturing is differentiated from more conventional biomanufacturing, and how to ensure and test for the highest level of quality.
25 years of CDMO services at the highest level
Richter-Helm BioLogics proudly celebrated the 25th company anniversary on August 22nd with the handover of the certificate by the Chamber of Commerce and Industry (IHK), Kiel.
Covid-19 vaccination at Richter-Helm
Richter-Helm is very pleased to be able to offer its employees to get vaccinated against Covid-19 by the company doctors.